Lisa Sheehan
Overview
Explore the profile of Lisa Sheehan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartup S, Morgan J, Cheng V, Barry P, Copson E, Cutress R, et al.
Int J Surg Protoc
. 2024 Mar;
28(1):20-26.
PMID: 38433867
Background: Despite a UK 5-year breast cancer survival rate of 86.6%, patients may develop breast cancer recurrence within the same breast after breast conserving surgery, as well as in the...
2.
Morgan J, Cheng V, Barry P, Copson E, Cutress R, Dave R, et al.
Eur J Surg Oncol
. 2022 Apr;
48(7):1510-1519.
PMID: 35410760
Introduction: Evidence based guidelines for the optimal management of breast cancer locoregional recurrence (LRR) are limited, with potential for variation in clinical practice. This national practice questionnaire (NPQ) was designed...
3.
Patel S, Zymvragoudakis V, Sheehan L, Lea T, Padayachee S, Donati T, et al.
J Vasc Surg
. 2015 Oct;
63(1):126-32.
PMID: 26482998
Objective: Infrapopliteal bypass is an established and effective method for limb salvage in patients with critical limb ischemia. Secondary interventions maybe required to maintain graft patency. The aim of this...
4.
Sheehan L, Anwar A, Kommu S
Int J Surg Case Rep
. 2015 Jan;
7C:42-6.
PMID: 25574770
Introduction: Bladder cancers are not very common in the young population below 20 years of age, especially in those who have not been exposed to chemotherapy, bladder augmentation surgery and...
5.
Michaelis L, Vaul J, Chumer K, Faul M, Sheehan L, DeCerce J
J Cardiovasc Manag
. 2004 Jun;
15(2):9-12.
PMID: 15185624
An independent expert panel conducted a multi-year research/education/advocacy initiative on the impact of the new drug-eluting stent technology. They conclude that this technology represents a "tipping point" in a series...